• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰岛素样生长因子1受体(IGF1R)在小细胞肺癌中的表达增加以及RNA干扰抑制IGF1R表达对人小细胞肺癌NCI-H446细胞生长的影响。

Increased insulin-like growth factor 1 receptor (IGF1R) expression in small cell lung cancer and the effect of inhibition of IGF1R expression by RNAi on growth of human small cell lung cancer NCI-H446 cell.

作者信息

Wang Zhigang, Lu Pingfang, Liang Zhu, Zhang Zhanfei, Shi Weicheng, Cai Xiaobi, Chen Chunyuan

机构信息

a The Affiliated Hospital of Guangdong Medical University , Zhanjiang , Guangdong , China and.

b Guangdong General Hospital of Armed Police Forces , Guangzhou , Guangdong , China.

出版信息

Growth Factors. 2015;33(5-6):337-46. doi: 10.3109/08977194.2015.1088533. Epub 2015 Oct 2.

DOI:10.3109/08977194.2015.1088533
PMID:26430715
Abstract

Insulin-like growth factor 1 receptor (IGF1R) is a tyrosine kinase receptor implicated in tumourigenesis that may be an attractive target for anti-cancer treatment. In this study, the expression and clinical significance of IGF1R were investigated in serum and lung cancer tissues from small cell lung cancinoma (SCLC). We also compared the effect of IGF1R up-regulation and IGF1R inhibition on viability and apoptosis of NCI-H446 cells. We found the concentration of IGF1R in blood serum was significantly increased and positive IGF1R protein in cancer tissue was more prevalent in SCLC. A statistically significant correlation among IGF1R-positve tumors, lymph node metastasis and local invasion was discussed. Furthermore, IGF1R overexpression lead to an increase of cell survival and suppressed cell apoptosis, IGF1R silencing mediated by RNAi abrogate this response of NCI-H446 cells. Our results further demonstrated that the effects of these treatments may be assigned to the effective inhibition of lung cancer cells from Akt/P27(Kip1) pathway in IGF-1R signaling. These features may have important implications for future anti-IGF1R therapeutic approaches.

摘要

胰岛素样生长因子1受体(IGF1R)是一种与肿瘤发生相关的酪氨酸激酶受体,可能是抗癌治疗的一个有吸引力的靶点。在本研究中,我们调查了小细胞肺癌(SCLC)患者血清和肺癌组织中IGF1R的表达及其临床意义。我们还比较了IGF1R上调和抑制对NCI-H446细胞活力和凋亡的影响。我们发现,SCLC患者血清中IGF1R浓度显著升高,癌组织中IGF1R蛋白阳性更为普遍。讨论了IGF1R阳性肿瘤、淋巴结转移和局部侵袭之间的统计学显著相关性。此外,IGF1R过表达导致细胞存活增加并抑制细胞凋亡,RNAi介导的IGF1R沉默消除了NCI-H446细胞的这种反应。我们的结果进一步证明,这些治疗的效果可能归因于对IGF-1R信号通路中肺癌细胞Akt/P27(Kip1)途径的有效抑制。这些特征可能对未来的抗IGF1R治疗方法具有重要意义。

相似文献

1
Increased insulin-like growth factor 1 receptor (IGF1R) expression in small cell lung cancer and the effect of inhibition of IGF1R expression by RNAi on growth of human small cell lung cancer NCI-H446 cell.胰岛素样生长因子1受体(IGF1R)在小细胞肺癌中的表达增加以及RNA干扰抑制IGF1R表达对人小细胞肺癌NCI-H446细胞生长的影响。
Growth Factors. 2015;33(5-6):337-46. doi: 10.3109/08977194.2015.1088533. Epub 2015 Oct 2.
2
MiR-30a suppresses non-small cell lung cancer progression through AKT signaling pathway by targeting IGF1R.微小RNA-30a通过靶向胰岛素样生长因子1受体,经由AKT信号通路抑制非小细胞肺癌进展。
Cell Mol Biol (Noisy-le-grand). 2015 May 28;61(2):78-85.
3
Enhanced tumor suppression by adenoviral PTEN gene therapy combined with cisplatin chemotherapy in small-cell lung cancer.腺病毒 PTEN 基因治疗联合顺铂化疗增强小细胞肺癌的肿瘤抑制作用。
Cancer Gene Ther. 2013 Apr;20(4):251-9. doi: 10.1038/cgt.2013.14. Epub 2013 Mar 8.
4
Fibroblast growth factor-inducible 14 regulates cell growth and multidrug resistance of small-cell lung cancer through the nuclear factor-κB pathway.成纤维细胞生长因子诱导蛋白14通过核因子κB途径调节小细胞肺癌的细胞生长和多药耐药性。
Anticancer Drugs. 2014 Nov;25(10):1152-64. doi: 10.1097/CAD.0000000000000153.
5
Upregulation of the inwardly rectifying potassium channel Kir2.1 (KCNJ2) modulates multidrug resistance of small-cell lung cancer under the regulation of miR-7 and the Ras/MAPK pathway.内向整流钾通道Kir2.1(KCNJ2)的上调在miR-7和Ras/MAPK信号通路的调控下调节小细胞肺癌的多药耐药性。
Mol Cancer. 2015 Mar 12;14:59. doi: 10.1186/s12943-015-0298-0.
6
Evodiamine induces G2/M arrest and apoptosis via mitochondrial and endoplasmic reticulum pathways in H446 and H1688 human small-cell lung cancer cells.吴茱萸碱通过线粒体和内质网途径诱导H446和H1688人小细胞肺癌细胞发生G2/M期阻滞和凋亡。
PLoS One. 2014 Dec 15;9(12):e115204. doi: 10.1371/journal.pone.0115204. eCollection 2014.
7
FIGNL1 is overexpressed in small cell lung cancer patients and enhances NCI-H446 cell resistance to cisplatin and etoposide.FIGNL1在小细胞肺癌患者中过表达,并增强NCI-H446细胞对顺铂和依托泊苷的耐药性。
Oncol Rep. 2017 Apr;37(4):1935-1942. doi: 10.3892/or.2017.5483. Epub 2017 Mar 1.
8
Adenovirus-mediated siRNA targeting c-Met inhibits proliferation and invasion of small-cell lung cancer (SCLC) cells.腺病毒介导的 c-Met 靶向 siRNA 抑制小细胞肺癌(SCLC)细胞的增殖和侵袭。
J Surg Res. 2011 Nov;171(1):127-35. doi: 10.1016/j.jss.2009.12.016. Epub 2010 Jan 14.
9
Lentivirus-mediated knockdown of NLK inhibits small-cell lung cancer growth and metastasis.慢病毒介导的NLK基因敲低抑制小细胞肺癌的生长和转移。
Drug Des Devel Ther. 2016 Nov 15;10:3737-3746. doi: 10.2147/DDDT.S87435. eCollection 2016.
10
Chan-Yu-Bao-Yuan-Tang induces apoptosis in NSCLC and SCLC cell lines via a mitochondria-mediated pathway.蟾鱼宝元汤通过线粒体介导的途径诱导非小细胞肺癌和小细胞肺癌细胞系凋亡。
Xenobiotica. 2011 Jul;41(7):593-602. doi: 10.3109/00498254.2011.565818. Epub 2011 Mar 29.

引用本文的文献

1
Current and future therapies for small cell lung carcinoma.小细胞肺癌的当前及未来治疗方法
J Hematol Oncol. 2025 Apr 1;18(1):37. doi: 10.1186/s13045-025-01690-6.
2
Mining of candidate genes related to body size in Chinese native pig breeds based on public data.基于公开数据挖掘中国地方猪种中与体型相关的候选基因
Sci Rep. 2025 Mar 21;15(1):9793. doi: 10.1038/s41598-025-88583-3.
3
Insulin Receptor Isoforms and Insulin Growth Factor-like Receptors: Implications in Cell Signaling, Carcinogenesis, and Chemoresistance.胰岛素受体亚型与胰岛素样生长因子受体:在细胞信号传导、致癌作用及化疗耐药性中的意义
Int J Mol Sci. 2023 Oct 9;24(19):15006. doi: 10.3390/ijms241915006.
4
IGF1R and MAPK15 Emerge as Potential Targets of Pentabromobenzylisothioureas in Lung Neuroendocrine Neoplasms.胰岛素样生长因子1受体(IGF1R)和丝裂原活化蛋白激酶15(MAPK15)成为五溴苄基异硫脲在肺神经内分泌肿瘤中的潜在靶点。
Pharmaceuticals (Basel). 2020 Oct 29;13(11):354. doi: 10.3390/ph13110354.
5
Future Options of Molecular-Targeted Therapy in Small Cell Lung Cancer.小细胞肺癌分子靶向治疗的未来选择
Cancers (Basel). 2019 May 17;11(5):690. doi: 10.3390/cancers11050690.
6
Molecular Signatures of the Insulin-like Growth Factor 1-mediated Epithelial-Mesenchymal Transition in Breast, Lung and Gastric Cancers.胰岛素样生长因子 1 介导的乳腺癌、肺癌和胃癌上皮-间充质转化的分子特征。
Int J Mol Sci. 2018 Aug 15;19(8):2411. doi: 10.3390/ijms19082411.
7
Insulin-like growth factor-1 receptor knockdown enhances radiosensitivity via the HIF-1α pathway and attenuates ATM/H2AX/53BP1 DNA repair activation in human lung squamous carcinoma cells.胰岛素样生长因子-1受体敲低通过HIF-1α途径增强人肺鳞癌细胞的放射敏感性并减弱ATM/H2AX/53BP1 DNA修复激活。
Oncol Lett. 2018 Jul;16(1):1332-1340. doi: 10.3892/ol.2018.8705. Epub 2018 May 11.
8
Nuclear insulin-like growth factor-1 receptor (IGF1R) displays proliferative and regulatory activities in non-malignant cells.细胞核胰岛素样生长因子-1受体(IGF1R)在非恶性细胞中表现出增殖和调节活性。
PLoS One. 2017 Sep 25;12(9):e0185164. doi: 10.1371/journal.pone.0185164. eCollection 2017.
9
Improved decision making for prioritizing tumor targeting antibodies in human xenografts: Utility of fluorescence imaging to verify tumor target expression, antibody binding and optimization of dosage and application schedule.优化人源异种移植瘤中肿瘤靶向抗体优先级的决策:利用荧光成像验证肿瘤靶点表达、抗体结合以及优化剂量和应用方案。
MAbs. 2017 Jan;9(1):140-153. doi: 10.1080/19420862.2016.1238996. Epub 2016 Sep 23.
10
Implications of Insulin-like Growth Factor 1 Receptor Activation in Lung Cancer.胰岛素样生长因子1受体激活在肺癌中的意义
Malays J Med Sci. 2016 May;23(3):9-21.